Pre-made Roledumab benchmark antibody ( Whole mAb, anti-RHD therapeutic antibody, Anti-CD240D/DIIIc/HDFNRH/RH30/RHCED/RHDVA(TT)/RHDel/RHPII/RHXIII/Rh4/RhII/RhK562-II/RhPI Antibody) for drug discovery and mechanism of action (MOA) research
Cat No.: GMP-Bios-ab-490
Pre-Made Roledumab biosimilar, Whole mAb, Anti-RHD Antibody: Anti-CD240D/DIIIc/HDFNRH/RH30/RHCED/RHDVA(TT)/RHDel/RHPII/RHXIII/Rh4/RhII/RhK562-II/RhPI therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Roledumab is a monoclonal antibody. It binds to RHD, the Rhesus factor antigen.
Delivery impact due to the Coronavirus Outbreak
With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.
|Catalog No.||Package||Price(In USD)||Qty (Quantity)||Sum(In USD)|
|Products Name (INN Index)||Pre-Made Roledumab biosimilar, Whole mAb, Anti-RHD Antibody: Anti-CD240D/DIIIc/HDFNRH/RH30/RHCED/RHDVA(TT)/RHDel/RHPII/RHXIII/Rh4/RhII/RhK562-II/RhPI therapeutic antibody|
|Highest_Clin_Trial (Jan '20)||Phase-II/III|
|100% SI Structure||None|
|99% SI Structure||None|
|95-98% SI Structure||None|
|Conditions Active||Haemolytic disease of newborn|
|Development Tech||EMABling Platform|